0 results available. Select is focused ,type to refine list, press Down to open the menu,
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous...
The following section summarizes insights on Cytosorbents Crp's 10 Year Price Total Return:
We've identified the following companies as similar to Cytosorbents Crp because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to 10 Year Price Total Return in the valuation category include:
The total change in price (adjusted of dividends and splits when applicable) over the last 10 years.
The 10 year price total return measures the total change in price (adjusted of dividends and splits when applicable) over the last 10 years. If the company pays dividends, the starting stock price is adjusted down to include the return in the form of dividends.
Last Close Price / Adj Prior Close Price
(-) 1
(=) Total Return
Ten Year Stock Price Total Return for Cytosorbents is calculated as follows:
Last Close Price [ 1.02 ] / Adj Prior Close Price [ 14.30 ]
(-) 1
(=) Total Return [ −92.9% ]
Prior price dividend adjustment factor is 1.00.
Read more about price close (split adjusted) and dividend adjustment factor
The chart above depicts the distribution of 10 year price total return for companies operating in the Healthcare sector in the Developed economic region. Over 3,130 companies were considered in this analysis, and 3,022 had meaningful values. The average 10 year price total return of companies in the sector is -29.2% with a standard deviation of 117.1%.
Cytosorbents Crp's 10 Year Price Total Return of -92.9% ranks in the 38.7% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 3,139 |
| Included Constituents | 3,022 |
| Min | -100.0% |
| Max | 633.3% |
| Median | -81.5% |
| Mean | -29.2% |
| Standard Deviation | 117.1% |
You can find companies with similar 10 year price total return using this stock screener.